Cargando…
Comparative transcriptomic analysis of mice liver treated with different AMPK activators in a mice model of atherosclerosis
Atherosclerosis is known to be the primary underlying factor responsible for the development of cardiovascular diseases. Suppression of AMP-activated protein kinase stimulates arterial deposition of excess lipids, resulting in the development of atherosclerotic lesions. In this study we successfully...
Autores principales: | Ma, Ang, Wang, Dongmei, An, Yuanyuan, Fang, Wei, Zhu, Haibo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5369987/ https://www.ncbi.nlm.nih.gov/pubmed/28178661 http://dx.doi.org/10.18632/oncotarget.15027 |
Ejemplares similares
-
AMPK activation enhances the anti-atherogenic effects of high density lipoproteins in apoE(−/−) mice
por: Ma, Ang, et al.
Publicado: (2017) -
Salsalate reduces atherosclerosis through AMPKβ1 in mice
por: Day, Emily A., et al.
Publicado: (2021) -
Atorvastatin inhibits endoplasmic reticulum stress through AMPK signaling pathway in atherosclerosis in mice
por: Xiong, Wangqiong, et al.
Publicado: (2020) -
Myeloid deletion and therapeutic activation of AMPK do not alter atherosclerosis in male or female mice
por: LeBlond, Nicholas D., et al.
Publicado: (2020) -
Balasubramide derivative 3C attenuates atherosclerosis in apolipoprotein E-deficient mice: role of AMPK-STAT1-STING signaling pathway
por: Cai, Dongcheng, et al.
Publicado: (2021)